Cancer News and Research

Latest Cancer News and Research

Researchers develop new technique to improve cancer treatments

An innovative technique to improve cancer treatments using tumour biopsies less than 30 minutes after they're taken has been developed at The University of Queensland.

25 Aug 2020

Researchers document comprehensive communication pathways in human cell infected with SARS-CoV-2

In the transmission of signals within the cell which, for example, stimulate cell growth or trigger metabolic processes, phosphate groups play an important biochemical role.

25 Aug 2020

Blood cancer patients are more vulnerable to the effects of COVID-19, study finds

A newly published study led by the Universities of Oxford and Birmingham has found that, compared to other cancers, patients with blood cancers are more vulnerable to the effects of the coronavirus pandemic.

25 Aug 2020

Survival of mesothelioma patients is improving, new data reveals

Mesothelioma is a rare, aggressive type of cancer with no cure. However, the latest data from the Australian Institute of Health and Welfare suggests survival is improving.

25 Aug 2020

Scientists identify two markers of inflammation that predict severity of COVID-19 cases

Mount Sinai scientists have identified two markers of inflammation that reliably predict the severity of COVID-19 cases and likelihood of survival, providing a foundation for a diagnostic platform and therapeutic targets, according to a study published in Nature Medicine in August.

25 Aug 2020

New strategies automate the assessment of stored red blood cell quality

Each year, nearly 120 million units of donated blood flow from donor veins into storage bags at collection centres around the world. The fluid is packed, processed and reserved for later use. But once outside the body, stored red blood cells (RBCs) undergo continuous deterioration. By day 42 in most countries, the products are no longer usable.

25 Aug 2020

Delivering split immunotoxins separately to cancer cells can reduce life-threatening side effects

Splitting one type of cancer drug in half and delivering the pieces separately to cancer cells could reduce life-threatening side effects and protect healthy, non-cancerous cells, a new study suggests.

25 Aug 2020

Highly expressed protein in lung cancer cells drives resistance to targeted therapies

A protein highly expressed in lung cancer cells drives resistance to targeted therapies, report researchers at the Medical University of South Carolina in the Journal of Thoracic and Cardiovascular Surgery.

25 Aug 2020

New, low-cost technology for subcutaneous injection of viscous formulations

MIT researchers have developed a simple, low-cost technology to administer powerful drug formulations that are too viscous to be injected using conventional medical syringes.

24 Aug 2020

Women with T1a breast cancers could benefit from hormone treatment

Many people diagnosed with breast cancers that are small but invasive could benefit from hormone treatment, a new study led by physicians at Roswell Park Comprehensive Cancer Center confirms. Their findings were published today in the journal JAMA Network Open.

24 Aug 2020

Researchers identify potential drug target for curtailing cancer metastasis

Researchers led by Ludwig Chicago Co-director Ralph Weichselbaum and Ronald Rock of the University of Chicago have identified in preclinical studies a potential drug target for curtailing cancer metastasis.

24 Aug 2020

Excessive fructose consumption can result in non-alcoholic fatty liver disease

Excessive consumption of fructose - a sweetener ubiquitous in the American diet - can result in non-alcoholic fatty liver disease (NAFLD), which is comparably abundant in the United States.

24 Aug 2020

Researchers find a new way to slow colon cancer metastasis

When cancer metastasizes and spreads throughout the body, it can severely change the prognosis of the disease. It is estimated that metastasis is responsible for 90 percent of cancer deaths.

24 Aug 2020

UH to participate as study site for Pfizer and BioNTech's COVID-19 vaccine

University Hospitals announced today plans to participate as a study site for the Phase 2/3 global study sponsored by Pfizer Inc. and BioNTech SE of an investigational vaccine, BNT162b2, against SARS-CoV-2.

24 Aug 2020

New criteria to differentiate between frontotemporal dementia and LATE disease

Working with their colleagues at the University of Pennsylvania, researchers at the University of Kentucky have found that they can differentiate between subtypes of dementia inducing brain disease.

24 Aug 2020

Researchers identify mechanisms leading to immune 'exhaustion' in severe viral infections

Melbourne researchers have identified mechanisms leading to the functional deterioration of the immune system in response to severe viral infections, such as HIV or COVID-19.

24 Aug 2020

New surgical approach is highly acceptable among women with ovarian cancer risk

A new two-stage surgical approach for cancer prevention is highly acceptable among premenopausal women at high risk of ovarian cancer, according to research led by Queen Mary University of London.

24 Aug 2020

New discovery about STING protein could lead to improved cancer immunotherapies

The immune protein STING has long been noted for helping protect against viruses and tumors by signaling a well-known immune molecule.

24 Aug 2020

New cancer vaccine is predicted to be more effective in human trials

Jefferson researchers developing a cancer vaccine to prevent recurrences of gastric, pancreatic, esophageal and colon cancers have added a component that would make the vaccine more effective.

24 Aug 2020

Accidental discovery of new antibiotic proven effective after several experiments

It all happened by chance. It was a hot summer day nine years ago. Inside the laboratory, the team was working on cancer research. On the lab bench, various medications were being tested on cancer cells.

24 Aug 2020